Literature DB >> 19098369

The role of transient receptor potential channels in metabolic syndrome.

Daoyan Liu1, Zhiming Zhu, Martin Tepel.   

Abstract

Metabolic syndrome is correlated with increased cardiovascular risk and characterized by several factors, including visceral obesity, hypertension, insulin resistance, and dyslipidemia. Several members of a large family of nonselective cation entry channels, e.g., transient receptor potential (TRP) canonical (TRPC), vanilloid (TRPV), and melastatin (TRPM) channels, have been associated with the development of cardiovascular diseases. Thus, disruption of TRP channel expression or function may account for the observed increased cardiovascular risk in metabolic syndrome patients. TRPV1 regulates adipogenesis and inflammation in adipose tissues, whereas TRPC3, TRPC5, TRPC6, TRPV1, and TRPM7 are involved in vasoconstriction and regulation of blood pressure. Other members of the TRP family are involved in regulation of insulin secretion, lipid composition, and atherosclerosis. Although there is no evidence that a single TRP channelopathy may be the cause of all metabolic syndrome characteristics, further studies will help to clarify the role of specific TRP channels involved in the metabolic syndrome. (Hypertens Res 2008; 31: 1989-1995).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098369     DOI: 10.1291/hypres.31.1989

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  18 in total

Review 1.  Canonical transient receptor potential channels in diabetes.

Authors:  Sarabeth Graham; Joseph P Yuan; Rong Ma
Journal:  Exp Biol Med (Maywood)       Date:  2012-01-26

Review 2.  On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease.

Authors:  K Smedlund; M Bah; G Vazquez
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2012-09

3.  Propofol restores transient receptor potential vanilloid receptor subtype-1 sensitivity via activation of transient receptor potential ankyrin receptor subtype-1 in sensory neurons.

Authors:  Hongyu Zhang; Peter J Wickley; Sayantani Sinha; Ian N Bratz; Derek S Damron
Journal:  Anesthesiology       Date:  2011-05       Impact factor: 7.892

4.  Capsaicin induces browning of white adipose tissue and counters obesity by activating TRPV1 channel-dependent mechanisms.

Authors:  Padmamalini Baskaran; Vivek Krishnan; Jun Ren; Baskaran Thyagarajan
Journal:  Br J Pharmacol       Date:  2016-06-21       Impact factor: 8.739

Review 5.  TRP channels and their implications in metabolic diseases.

Authors:  Zhiming Zhu; Zhidan Luo; Shuangtao Ma; Daoyan Liu
Journal:  Pflugers Arch       Date:  2010-11-26       Impact factor: 3.657

6.  The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.

Authors:  Xiaoliang Zhang; Zhixia Song; Yinfeng Guo; Min Zhou
Journal:  Mol Cell Biochem       Date:  2014-10-09       Impact factor: 3.396

7.  Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes.

Authors:  Sarabeth Graham; Yves Gorin; Hanna E Abboud; Min Ding; Duck Yoon Lee; Honglian Shi; Yanfeng Ding; Rong Ma
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-27       Impact factor: 4.249

Review 8.  Vanilloid receptors--do they have a role in whole body metabolism? Evidence from TRPV1.

Authors:  Andrea Zsombok
Journal:  J Diabetes Complications       Date:  2013-01-16       Impact factor: 2.852

9.  4-Hydroxynonenal dependent alteration of TRPV1-mediated coronary microvascular signaling.

Authors:  Daniel J DelloStritto; Pritam Sinharoy; Patrick J Connell; Joseph N Fahmy; Holly C Cappelli; Charles K Thodeti; Werner J Geldenhuys; Derek S Damron; Ian N Bratz
Journal:  Free Radic Biol Med       Date:  2016-09-25       Impact factor: 7.376

10.  TRPV1 Channels and Gastric Vagal Afferent Signalling in Lean and High Fat Diet Induced Obese Mice.

Authors:  Stephen J Kentish; Claudine L Frisby; Stamatiki Kritas; Hui Li; George Hatzinikolas; Tracey A O'Donnell; Gary A Wittert; Amanda J Page
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.